Papers

2

Total Citations

160

H-Index

2

About

Karl Gruber is a pioneering figure in the development of high-throughput mass spectrometric immunoassays (MSIA), a field that bridges proteomics and clinical diagnostics. His major contributions center on creating automated, robust methods for analyzing proteins directly from complex biological fluids, such as plasma. In his seminal 2001 work, Gruber introduced a 96-well-format robotic workstation equipped with antibody-derivatized affinity pipet tips, enabling the parallel extraction and mass spectrometric quantification of specific proteins like β-2 microglobulin. This innovation dramatically increased throughput while maintaining sensitivity and specificity. His 2002 follow-up paper further refined these techniques for broader protein characterization, laying the groundwork for high-speed, multiplexed biomarker analysis. These two foundational papers have collectively garnered over 160 citations, underscoring their lasting impact on both analytical chemistry and clinical research. Gruber’s work is notable for its practical elegance—transforming a labor-intensive process into a scalable, automated system that has influenced modern proteomic workflows and diagnostic assay development.

Research Focus

Key Achievements

2
H-Index
2
Papers
160
Total Citations
80
Avg Citations/Paper
🏆 Most Cited Paper
Determination of β-2 Microglobulin Levels in Plasma Using a High-Throughput Mass Spectrometric Immunoassay System
85 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Arizona State University, Intrinsic LifeSciences (United States)

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago